Organogenesis Holdings
ORGO
67 hedge funds and large institutions have $161M invested in Organogenesis Holdings in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 4 reducing their positions, and 7 closing their positions.
738% more capital invested
Capital invested by funds: $19.2M → $161M (+$142M)
650% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 4
257% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 7
34% more funds holding
Funds holding: 50 → 67 (+17)
12.31% more ownership
Funds ownership: 4.73% → 17.04% (+12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$26.2M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$8.77M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$8.58M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$6.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$384K |
| 2 |
Squarepoint
New York
|
-$259K |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$140K |
| 4 |
HF
HRT Financial
New York
|
-$109K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$92.3K |
ORGO Hedge Fund Activity: Q4 2020 in Review
67 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q4 2020, worth a combined $161M — up 738% from $19.2M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ORGO positions and 7 closed out — a net gain of 18 holders — while 30 added to existing stakes and 4 trimmed.
The largest buyer was Avidity Partners Management, opening a new position worth an estimated $26.2M. The largest seller was Hussman Strategic Advisors, exiting entirely with an estimated $384K sold.
- 67 institutional investors held Organogenesis Holdings (ORGO) as of Q4 2020, up from 50 in Q3 2020.
- Funds reported $161M of Organogenesis Holdings stock for Q4 2020, up 738% quarter-over-quarter.
- 25 funds opened new Organogenesis Holdings positions in Q4 2020 and 7 closed out, a net change of +18 holders.
- The largest Organogenesis Holdings buyer in Q4 2020 was Avidity Partners Management, an estimated $26.2M added.
- The largest Organogenesis Holdings seller in Q4 2020 was Hussman Strategic Advisors, an estimated $384K sold.
Based on aggregated 13F filings for Q4 2020.